Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK2 | O60674 | 2/20 | 0.60 |
| ▸ | HDAC1 | Q13547 | 15/20 | 0.60 |
| ▸ | JAK3 | P52333 | 1/20 | 0.48 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.46 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.46 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.46 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.46 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.46 |
| ▸ | ABL1 | P00519 | 2/20 | 0.46 |
| ▸ | PDGFRB | P09619 | 2/20 | 0.46 |
| ▸ | KDR | P35968 | 2/20 | 0.46 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.46 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.46 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.46 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.46 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.46 |
| ▸ | NCOR1 | O75376 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.45 |
| ▸ | AURKA | O14965 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL700350 | 0.94 | HDAC1 (0.61) | JAK2HDAC1HDAC3HDAC2HDAC11 | |
| SCHEMBL699043 | 0.87 | JAK2 (0.55) | JAK2HDAC1JAK3HDAC3HDAC2 | |
| SCHEMBL12789790 | 0.87 | HDAC1 (0.48) | JAK2HDAC1HDAC3HDAC2HDAC11 | |
| SCHEMBL3353340 | 0.85 | HDAC1 (0.52) | JAK2HDAC1HDAC3HDAC2HDAC11 | |
| SCHEMBL701663 | 0.85 | HDAC1 (0.63) | JAK2HDAC1HDAC3HDAC2HDAC11 | |
| SCHEMBL12790694 | 0.84 | TNIK (0.47) | JAK2HDAC1HDAC3HDAC2HDAC11 | |
| SCHEMBL699310 | 0.82 | HDAC1 (0.78) | JAK2HDAC1HDAC3HDAC2HDAC11 | |
| SCHEMBL699649 | 0.82 | HDAC1 (0.79) | JAK2HDAC1HDAC3HDAC2HDAC11 | |
| SCHEMBL699938 | 0.80 | JAK2 (0.47) | JAK2HDAC1JAK3HDAC3HDAC2 | |
| SCHEMBL12789786 | 0.80 | HDAC1 (0.48) | HDAC1HDAC3HDAC2HDAC11HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8124764-B2 | Fused heterocyclyc inhibitor compounds | GILEAD SCIENCES, INC. (US) | 2012-02-28 | — | — | US | claimed |
| US-20100029638-A1 | FUSED HETEROCYCLYC INHIBITOR COMPOUNDS | GILEAD SCIENCES, INC. | 2010-02-04 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100029638-A1 | FUSED HETEROCYCLYC INHIBITOR COMPOUNDS | HDAC1, HDAC11, HDAC7 | JAK2 745/4885HDAC1 1/4885JAK3 1359/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.